Publications by authors named "Daniel Pambianco"

As the number and complexity of endoscopic procedures increase, the role of sedation has been integral in patient and physician satisfaction. This article discusses the advances of computer-assisted and patient-controlled platforms. These computer-assisted and patient-controlled platforms use different anesthetics and analgesics, all with the intent of achieving improved consistency in the level of sedation, appropriate to the needs of patients, while also improving patient safety.

View Article and Find Full Text PDF
Article Synopsis
  • Remimazolam is being tested as a fast-acting sedative for procedures like colonoscopies, with this trial being the fourth study focused on its use in procedural sedation.
  • The trial involved 162 patients aged 18 to 70, comparing the efficacy and safety of remimazolam to midazolam, with results showing over 92% success in the remimazolam group compared to 75% for midazolam.
  • The findings indicated that remimazolam has a promising safety profile and effectiveness, prompting the need for further phase III trials to confirm these results.
View Article and Find Full Text PDF

Background: This exploratory study was the first study of remimazolam in patients to assess the safety and efficacy of different single doses for procedural sedation.

Methods: Patients scheduled to undergo a diagnostic upper gastrointestinal endoscopy were randomized to receive 1 of 3 doses of remimazolam or midazolam (25 per group) in a double-blind manner. After a single dose of study drug to achieve sedation, patients underwent gastroscopy.

View Article and Find Full Text PDF

Food and Drug Administration (FDA) advisory panels and committees play a critical role in advising the FDA on the safety and efficacy of medical devices and drugs marketed in the US. Advisory panel recommendations are used by the FDA to make decisions regarding medical products. Currently, the FDA utilizes over 50 advisory panels that serve the three major FDA centers, including the Centers for Biologics, Drugs and Device Products.

View Article and Find Full Text PDF

Background: The SEDASYS System is an investigational computer-assisted personalized sedation system integrating propofol delivery with patient monitoring to enable endoscopist/nurse teams to safely administer propofol.

Objective: To compare the safety and effectiveness of the SEDASYS System to the current standard of care for sedation during routine endoscopic procedures.

Design: Nonblinded multicenter randomized comparative study.

View Article and Find Full Text PDF
Future directions in endoscopic sedation.

Gastrointest Endosc Clin N Am

October 2008

The role of sedation in endoscopic procedures has increased and so has the demand for advances in its administration. The pursuit of new agents or administration techniques and their study specific to endoscopic nonsurgical procedures is necessary to improve patient comfort and safety.The science of moderate and deep sedation specific to endoscopy is fledgling but approaching new horizons.

View Article and Find Full Text PDF

Background: Demand for colonoscopy and EGD procedures is increasing. Impediments to performing these examinations persist. Patients perceive these procedures as unpleasant and painful.

View Article and Find Full Text PDF

Background: The tablet formulation of sodium phosphate (NaP) is a prescription osmotic purgative that has been marketed since 2001. The use of NaP tablets in patients with constipation has not been studied previously.

Objective: This study assessed the tolerability and efficacy of 28 days of therapy with NaP tablets (1.

View Article and Find Full Text PDF

Objective: The aim of this study was to compare the colon-cleansing effectiveness, ease of consumption, and side effect profiles of two commercially available preparations of sodium phosphate: liquid Fleet Phospho-soda and Visicol tablets.

Methods: Outpatients undergoing elective colonoscopy were sequentially randomized to one of two preparation groups: liquid: 45 ml at 7:00 PM, 45 ml 3 h before colonoscopy; or tablet: 20 tablets at 7:00 PM, 20 tablets 3-5 h before colonoscopy. Subjects rated preparation tolerability on a 5-point Likert scale.

View Article and Find Full Text PDF